PATENT CLAIM ANALYSIS

Application Number: 15772910
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["540", "467000"]

Abstract:
The present invention provides compositions and methods for providing controllable local delivery of a conjugate of bortezomib (Btz) and a bisphosphonate to promote bone formation. In certain embodiments, the invention is used as a treatment for a subject with diseases and disorders characterized by bone loss.

Claim (Index 24):
The method of any of  claim 21 , wherein the compound is selected from the group consisting of: or\n a pharmaceutically acceptable salt thereof, an isomer thereof, or a mixture of isomers thereof.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 93.0
- Lexical Diversity: 1.2439
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15772893', '15094733', '14378089', '10576228', '15951585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7429904979162878
- 35 USC 102 Novelty (BERT): 0.5339886956117879
- Combined Prediction Score: 0.7220903176858379
- Mean Citation Score: 295.387648
- Max Citation Score: 362.4084
- Similarity Product: 272.2829310063601

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test